IHS Chemical Week

Regions :: Western Europe :: Switzerland

Lonza and OncoMed sign process development and manufacturing deal

12:19 AM MDT | October 23, 2012 | Deepti Ramesh

Lonza says it has signed an agreement with OncoMed Pharmaceuticals (Redwood City, CA), a clinical-stage biopharmaceutical company dedicated to improving cancer treatment, for the development and manufacture of OncoMed’s pipeline of anticancer stem-cell therapeutics. Lonza will produce material at its mammalian manufacturing facility at Slough, UK, under the deal. The multiproduct GS system license provides access to Lonza’s GS Gene Expression System and Version 8 Media and Feeds manufacturing platform.   OncoMed’s pipeline is focused on the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa